The IDEAL team will test this new model on targets known to be relevant in ovarian cancer, the deadliest of gynecologic ...

Pregnancy complicates a cancer diagnosis in many ways. So cancer treatment may need to be adjusted. Here’s what we know so ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...

Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

When Ellie Wilcock was hit by sharp pains in her abdomen and sudden bouts of fatigue in 2022, she blamed it on a urinary ...

ATA 2024 spotlighted new research to help endocrinologists manage the subsequent fertility, bone health, and cardiovascular ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

In this excerpt from "Too Young for Cancer," Katie Coleman describes receiving her cancer diagnosis after years of having her symptoms misdiagnosed.